Recent Quotes (30 days)

You have no recent quotes
chg | %

Helix Biopharma Corp.  

(Public, TSE:HBP)   Watch this stock  
Find more results for HBP
0.00 (0.00%)
Oct 21 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 1.55 - 2.25
Open     -
Vol / Avg. 0.00/4,821.00
Mkt cap 137.61M
P/E     -
Div/yield     -
EPS -0.11
Shares 89.81M
Beta -0.14
Inst. own 0%

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -203.22% -112.21%
Return on average equity -280.97% -128.76%
Employees 13 -
CDP Score - -


3-305 Industrial Pky S
+1-905-8412300 (Phone)
+1-905-8412244 (Fax)

Website links


Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. L-DOS47 is under clinical study for the treatment of non-small cell lung cancer (NSCLC). L-DOS47 has completed preclinical testing and manufacturing development, following which, regulatory approvals are obtained in Poland and the United States to conduct Phase I/II and Phase I clinical studies. V-DOS47 is an antibody DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor (VEGFR2).

Officers and directors

Sven Rohmann M.D., Ph.D. Chairman of the Board, Chief Executive Officer
Age: 52
Photios Michalargias Chief Financial Officer
Age: 50
Patrick Frankham Ph.D. Chief Operating Officer
Age: 43
Heman Chao Ph.D. Chief Scientific Officer
Age: 51
George J. Anders Director
Albert G. Beraldo Director
Sylwester Eugeniusz Cacek Director
Theordore Witek Jr. Director
Slawomir Majewski M.D. Independent Director
Age: 57